11/1/24 First 3Dicom enterprise sale in United States. 5000 3Dicom licenses purchased by Techworks 4 Good on behalf of U.S Veterans. Whilst the details of the enterprise sale are commercial-in-confidence, the revenue generated from this order exceeds the total direct-to-consumer sales of the 3Dicom software in the 2023 Calendar Year of ~AUD $50,000 by more than 40%.
1/2/24 First Enterprise sale in United States education market with Roseman University of Health Sciences. 50 3Dicom R&D licenses and 5000 3Dicom patient licenses. Approx A$152,000
8/2/24 CG1 $850,000 Investment confirmation
14/3/24 Strategic Investment from Craig Sellars. A$1,000,000 from Craig Sellars a world renowned leading US technology and blockchain developer and entrepreneur, and co founder of Tether and Self ID inc. Investment at 0.15c per share at the time a 36% premium to the last capital raise price.
15/5/24 Significant follow on investment from Marin and Sons LLC. A$773,000 at 0.16 per share. Marin and Sons LLC wave monthly retainer for success based renumeration.
12/6/24 Launch of licensable Zero-Footprint 3Dicom online viewer.
4/7/24 A$1,000,000 received from Craig Sellars a 42% premium to the last close price of 10.5c.
15/7/24 3Dicom for Veterans Initiative expands to Texas. Purchase order for 5000 3Dicom licenses for US Veterans Austin Texas. Total contract value A$80,000.
8/8/24 Technical Integration of Relu dental A.I Model.
20/11/24 MOU and Strategic Placement with Provider Network Solutions. Singular Health (Singular Health) and Provider Network Solutions (PNS), a Miami-based Managed Service Organisation (MSO) with more than 3.7 million Member Plans under management, have signed a Memorandum of Understanding (MOU) for Singular Health’s 3Dicom software and agreed to a A$500,000 cornerstone equity investment in Singular Health. The MOU provides a definitive pathway towards an initial commercial pilot, a subsequent full-scale rollout throughout the PNS network, and a planned National rollout to PNS’ wider network.
23/12/24 Engagement of Dr Ronny Low as Technical Advisor. In a demonstration of confidence in the company’s vision and potential, Dr Low has recently acquired 7,810,968 shares in associated entities. 6,699,857 have been purchased on market in the last two weeks. This investment reflects Dr Low’s commitment to aligning personal interests with those of our shareholders. A highly accomplished radiologist, Dr Low has held numerous positions within RANZCR and currently serves as a member of the Clinical Radiology Education and Training Committee and in January commences a term on their Clinical Radiology Curriculum Advisory Committee.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)